Remifentanil Versus Fentanyl for Tonsillectomy and Adenoidectomy Surgery in Pediatric Ambulatory Surgical Patients: A Randomized, Double-Blinded Study.

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000029026

Enrollment

Unknown

Registered

2020-01-11

Start date

2020-02-01

Completion date

Unknown

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

tonsil and adenoid hypertrophy

Interventions

Group 1:Remifentanil

Group 2:fentanyl

Eligibility

Sex/Gender

All

Age

2 Years to 6 Years

Inclusion criteria

Inclusion criteria: 1. Aged 2-6 years; 2. American Sociaty of Anesthesiologists (ASA) grades I; 3. Patients scheduled for tonsillectomy and adenoidectomy ambulatory surgery.

Exclusion criteria

Exclusion criteria: 1. Patients with a known allergy to the study drugs; 2. Patients with congenital disease,asthma,preexisting pneumothorax.

Design outcomes

Primary

Measure	Time frame
HR;MAP;	—

Countries

China

Contacts

Public ContactYe Yuan

The First Hospital of Jilin University

yeyuan1225@sina.com+86 13604430557

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026